July 9, 2025 - 03:50

RADNOR, Pa., July 08, 2025—Lincoln Financial has announced the launch of its third quarter edition of Market Intel Exchange, a detailed report designed to provide a thorough analysis of prevailing market and economic trends. This edition features a comprehensive chartbook that synthesizes key insights and data to help investors make informed decisions in a rapidly evolving financial landscape.
The report is a product of extensive in-house research and collaboration with prominent asset managers associated with Lincoln's multimanager platform. By combining expert analyses and data-driven insights, the Market Intel Exchange aims to equip investors with the necessary tools to navigate the complexities of today’s market environment.
As economic indicators continue to shift, this report highlights crucial trends and investment opportunities, offering valuable guidance for both seasoned and novice investors alike. The insights provided are essential for understanding the current economic climate and making strategic investment choices.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...